1-FENİL-2-(1H-İMİDAZOL-1-İL)ETANON OKSİM ESTERLERİNİN SENTEZİ VE BİYOLOJİK ETKİLERİ ÜZERİNDE ÇALIŞMALAR
Date
2020-02-19Author
YURTOĞLU, SİBEL
xmlui.dri2xhtml.METS-1.0.item-emb
Acik erisimxmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Yurtoglu, S., Studies on Synthesis and Biological Effects of 1-Phenyl-2-(1H-imidazol-1-yl) ethanone oxime esters , Hacettepe University, Institute of Health Sciences, MS Thesis in Pharmaceutical Chemistry, Ankara, 2020. In this study, a series of 1-phenyl-2- (1H-imidazol-1-yl) ethanone oxime ester derivatives that are designed based on the general structure of azole group antifungals was synthesized. Their structures were elucidated by using spectral methods and elemental analysis results and also, antifungal and antibacterial activities were evaluated. The antibacterial activities of all compounds against studied Gram (+) and Gram (-) bacteria were found to be very low compared to the standard compound gentamicin. Sorbic acid ester derivative compound 5c, (MIC: 4 μg / mL) was found to have close activity with against to C. albicans and C. parapsilosis to the standard compound fluconazole (MIC: 0,5 μg / mL). The structure-activity relationship between the type and the length of the alkyl chain of the oxime ester structure and the antifungal activity was investigated; however, no clear relationship could be established between the structural properties of the alkyl chain and the antifungal activity. Molecular docking studies were performed in the light of crystallographic data, which provide detailed insights into binding and molecular determinants of azoles in CYP51 binding site. Molecular docking studies showed that compound 5c fit in the active site of CACYP51 and fulfilled the molecular determinants for the enzyme’s inhibition, in line with the fact that azole antifungals inhibit fungal CYP51.